PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 134.00
+2.00 (1.52%)
Oct 26, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 4.95 billion as of October 26, 2026. It is the 33,534th most valuable company in the world and the 3,081st biggest in Japan. Its market cap has decreased by 18.63% in one year.
Market Cap
4.95B
Enterprise Value
2.62B
Revenue
737.27M
Global Rank
Country Rank
#3,081 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 4.95B, a decrease of -72.24%. That is a compound annual growth rate of -42.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 4.95B | -13.99% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 6.35B |
| MEDINET | 6.24B |
| CellSource | 6.11B |
| SUSMED,Inc. | 5.87B |
| Soiken Holdings | 5.68B |
| Cyfuse Biomedical K.K. | 5.63B |
| BrightPath Biotherapeutics | 5.56B |
| Kringle Pharma | 5.00B |